Repeated sessions of electrical stimulation to brain networks associated with memory improved verbal learning in some Alzheimer’s disease patients for up to eight weeks in a preliminary trial led by UT Southwestern Medical Center researchers. The findings, published in The Journal of Prevention of Alzheimer’s Disease, indicate that while future trials are needed, neurostimulation shows early promise as a treatment for Alzheimer’s and other neurodegenerative disorders, such as Lewy body dementia.
Ebola cases in Uganda rise to 14 as new cluster emerges, posing a challenge to health workers
Uganda’s Ebola caseload increased to 14 in the last week, Africa’s top public health agency said Thursday, with a new cluster emerging from a 4-year-old child who recently died of the infectious disease.
Flexible deployment of nurses drastically reduces neonatal transport, finds study
Due to capacity problems, about 600 babies have to be moved to another Neonatal Intensive Care Unit (NICU) every year. Researchers from the University of Twente’s CHOIR research center, the Amalia Children’s Hospital Nijmegen and the Emma Children’s Hospital Amsterdam investigated an innovative solution.
How brain cells compete to shape our minds from development to aging
In a recently published review, researchers led by Prof. Wu Qingfeng at the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences explored the ongoing process of neural cell competition (NCC), a fundamental mechanism that shapes the brain across the lifespan.
Levels of select vitamins and minerals in pregnancy may be linked to lower midlife blood pressure risk
Women with higher levels of essential minerals circulating in their blood during pregnancy, particularly copper and manganese, along with vitamin B12, had a lower risk of developing high blood pressure in middle age, about 20 years later, according to research presented at the American Heart Association’s Epidemiology and Prevention | Lifestyle and Cardiometabolic Health Scientific Sessions 2025. The meeting is being held in New Orleans, March 6–9, 2025, and offers the latest science on population-based health and wellness and implications for lifestyle.
Exposure to wildlife and forest walks can help ease symptoms of PTSD in US war veterans
A new study published in the journal Human-Animal Interactions has revealed that exposure to wildlife and forest walks can help ease the symptoms of post traumatic stress disorder (PTSD) in US war veterans.
Q&A: How closely monitoring blood pressure of postpartum mothers can sharply reduce emergency hospital visits
When Emily Rosenfeld was doing a fellowship in maternal-fetal medicine at Rutgers Robert Wood Johnson Medical School (RWJMS), she noticed that many patients were returning to the hospital for hypertension.
Diet-related brain inflammation: Three days of high-fat eating impair memory in aged rats
Just a few days of eating a diet high in saturated fat could be enough to cause memory problems and related brain inflammation in older adults, a new study in rats suggests.
High temperatures could affect brain function in preadolescents
Exposure to high ambient temperatures is associated with lower connectivity in three brain networks in preadolescents, suggesting that heat may impact brain function. This is the conclusion of a study led by the Barcelona Institute for Global Health (ISGlobal) and IDIBELL, in collaboration with Erasmus University Medical Center Rotterdam (ERASMUS MC) and the Networked Biomedical Research Center (CIBER): areas of Epidemiology and Public Health (CIBERESP), and Mental Health (CIBERSAM). The results have been published in the Journal of the American Academy of Child & Adolescent Psychiatry.
Chemo-immunotherapy approach shows potential benefit in patients with advanced HPV-negative head and neck cancer
Researchers from the University of Chicago Medicine Comprehensive Cancer Center have demonstrated the potential of a novel treatment approach including immunotherapy to treat advanced human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC). More than half of study participants had 50% or more of their tumors shrink after receiving the immunotherapy drug nivolumab with chemotherapy, followed by response-adaptive chemo-radiation therapy.